Entos Pharmaceuticals Inc. — Form D
Entos Pharmaceuticals Inc. of EDMONTON, A0, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-26. The offering totals $4.0M, of which $100K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-05-26
- Form: D
- Accession: 0001567619-20-011158
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $4.0M
- Amount sold: $100K
- Remaining: $3.9M
- Investors: 1
- Date of first sale: 2020-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367695
Issuer
- Name: Entos Pharmaceuticals Inc.
- CIK: 0001812824
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Incorporated: 2016
- Address: 2500-10220 103 AVE NW, EDMONTON, A0, T5J 0K4
- Phone: 780-862-7445
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Roy Duncan | Director | Edmonton, A0 |
| Andries Zijlstra | Director | Edmonton, A0 |
| John Lewis | Executive Officer | Gibsonia, PA |
| Arun Raturi | Executive Officer | Edmonton, A0 |
More